Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia

Journal of Neuroscience

Volumn 16, Issue 19, 1996, Pages 6021-6037

  Giulian, Dana ^a   Haverkamp, Lanny J ^a   Yu, J H ^a   Karshin, William ^a   Tom, D ^a   Li, Jun ^a   Kirkpatrick, Joel ^b   Kuo, Y M ^c   Roher, A E ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; immune system; microglia; neurotoxicity; plaques; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; NEUROTOXIN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; ENCEPHALITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOREACTIVITY; MICROGLIA; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SENILE PLAQUE; SEQUENCE ANALYSIS;

EID: 0029811105     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-19-06021.1996     Document Type: Article

References (73)

1. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW (1993) Cytotoxicity of microglia. Glia 7:111-118.
2. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE (1989) Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 24:548-557.
3. Beckman JS, Beckman T, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrate: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 87:1620-1627.
4. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
5. Bolsi D (1927) Placche senile e microglia. Riv Patol Nerv Ment 32:65-72.
6. Breitner JCS, Gau BA, Welsh KA (1990) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44:227-232.
7. Cotman CW, Pike CJ, Copani A (1992) β-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol Aging 13:587-590.
8. Davies P (1994) Neuronal abnormalities, not amyloid, are the cause of dementia in Alzheimer's disease. In: Alzheimer's disease (Terry RD, Katzman R, Bick KL, eds), pp 327-333. New York: Raven.
9. Davis TL, Wiley RG (1989) Immunotoxin, OX-42-saporin, destroys cerebellar Purkinje cells after intraventricular injection in rats. Brain Res 504:216-222.
10. Denis M (1994) Human monocytes/macrophages: NO or no NO? J Leukoc Biol 55:682-684.
11. Eikelenboom P, Zhan S-S, van Gool WA, Allsop D (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 15:447-450.
12. Fraser PE, Nguyen JT, Inouye H, Surewicz WK, Selkoe DJ, Podlisny MB, Kirschner DA (1992) Fibril formation by primate, rodent, and Dutchhemorrhagic analogues of Alzheimer amyloid β protein. Biochemistry 31:10716-10723.
13. Games D, Khan KM, Soriano FG, Keim PS, Davis DL, Bryant K, Lieberburg I (1992) Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol Aging 13:569-576.
14. Giaccone G, Tagliavini F, Linoli G, Bouras C, Frigerio L, Frangione B, Bugiani O (1989) Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 97:232-238.
15. Giulian D (1992) Microglia and diseases of the nervous system. In: Current neurology, Vol 12 (Appel SH, ed), pp 23-54. St. Louis, MO: Mosby.
16. Giulian D, Baker TJ (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178.
17. Giulian D, Robertson C (1990) Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27:33-42.
18. Giulian D, Chen J, Ingeman JE, George J, Noponen M (1989) The role of mononuclear phagocytes in wound healing after traumatic injury to the adult mammalian brain. J Neurosci 9:4416-4429.
19. Giulian D, Vaca K, Corpuz M (1993a) Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13:29-37.
20. Giulian D, Corpuz M, Chapman S, Mansouri M, Robertson C (1993b) Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 36:681-693.
21. Giulian D, Li J, Xi J, George J, Rutecki P (1994) The impact of microglia-derived cytokines upon gliosis in the CNS. Dev Neurosci 16:128-136.
22. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatrick JB (1995a) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27:119-137.
23. Giulian D, Li J, Bartel S, Broker J, Li X, Kirkpatrick JB (1995b) Cell-surface morphology identifies microglia to be a distinct class of mononuclear phagocytes. J Neurosci 15:7712-7726.
24. Gowing E, Roher AE, Woods AS, Cotter RJ, Chaney M, Little SP, Ball MJ (1994) Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 269:10987-10990.
25. Harris ME, Carney JM, Cole PS, Hensley K, Howard BJ, Martin L, Bummer P, Wang Y, Pedigo Jr NW, Butterfield DA (1995) β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. NeuroReport 6:1875-1879.
26. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91:3270-3274.
27. Howlett DR, Jennings KH, Lee DC, Clark MSG, Brown F, Wetzel R, Wood SJ, Camilleri P, Roberts GW (1995) Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4:23-32.
28. Ignarro LJ (1990) Nitric oxide. Hypertension 16:477-483.
29. Koh JY, Yang LL, Cotman CW (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 533:315-320.
30. Koo EH, Park L, Selkoe DJ (1993) Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc Natl Acad Sci USA 90:4748-4752.
31. Kuo Y-M, Emmerlings MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE (1996) Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077-4081.
32. Lees GJ (1993) Nitric oxide is produced by microglia. J Neurol Sci 114:119-122.
33. Lorenzo A, Yankner BA (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91:12243-12247.
34. Lucca U, Tettamanti M, Forloni G, Spagnoli A (1994) Nonsteroidal anti-inflammatory drug use in Alzheimer's disease. Biol Psychiatry 36:854-856.
35. Masliah E, Terry RD, Mallory M, Alford M, Hansen LA (1990) Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 137:1293-1297.
36. Masliah E, Mallory M, Deerinck T, DeTeresa R, Lamont S, Miller A, Terry RD, Carragher B, Ellisman M (1993) Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J Neuropathol Exp Neurol 52:619-632.
37. Mattson MP, Rydel RE (1992) β-Amyloid precursor protein and Alzheimer's disease: the peptide plot thickens. Neurobiol Aging 13:617-621.
38. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
39. May PC, Gitter BD, Waters DC, Simmons LK, Becker GW, Small JS, Robison PM (1992) β-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol Aging 13:605-607.
40. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79:195-200.
41. McGeer PL, McGeer E, Rogers J, Sibley J (1990) Anti-inflammatory drugs and Alzheimer disease. Lancet 335:1037.
42. Meda L, Cassatella MA, Szendrel GI, Otvos L, Jr, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374:647-650.
43. Mirra S, Heyman A (1993) CERAD guide to the neuropathological assessment of Alzheimer's disease and other dementias. Decatur, GA: Consortium to Establish a Registry for Alzheimer's Disease (CERAD).
44. Mrak RE, Sheng JG, Griffin WST (1995) Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 26:816-823.
45. Perlmutter LS, Scott SA, Barron E, Chui HC (1992) MHC class II-positive microglia in human brain: association with Alzheimer lesions. J Neurosci Res 33:549-558.
46. Piani D, Frei K, Do K, Cuénod M, Fontana A (1991) Murine brain macrophages induce NMDA receptor-mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 133:159-162.
47. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW (1991) Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur J Pharmacol 207:367-368.
48. Pike CJ, Burdick D, Walencewicz AJ (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
49. Pike CJ, Overman MJ, Cotman CW (1995) Ammo-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem 270:23895-23898.
50. Podlisny MB, Stephenson DT, Frosch MP, Lieberburg I, Clemens JA, Selkoe DJ (1992) Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol Aging 13:561-567.
51. Pollack SJ, Sadler IIJ, Hawtin SR, Tailor VJ, Shearman MS (1995) Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion. Neurosci Lett 197:211-214.
52. Price DL, Borchelt DR, Walker LC, Sisodia SS (1992) Toxicity of synthetic Aβ peptides and modeling of Alzheimer's disease. Neurobiol Aging 13:623-625.
53. Rio-Hortega P (1932) Microglia. In: Cytology and cellular pathology of the nervous system (Penfield W, ed), pp 481-584. New York: Hocker.
54. Rogers J, Luber-Nardo J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9:339-349.
55. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I (1992) Complement activation by β-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 89:10016-10020.
56. Roher AE, Palmer KC, Chau V, Ball MJ (1988) Isolation and characterization of Alzheimer's disease paired helical filament cytoskeletons: differentiation from amyloid plaque core protein. J Cell Biol 107:2703-2716.
57. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD (1993a) Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 268:3072-3083.
58. Roher AE, Palmer KC, Yurewicz EC, Ball MJ, Greenberg BD (1993b) Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J Neurochem 61:1916-1926.
59. Schnabel J (1993) New Alzheimer's therapy suggested. Science 260:1719-1720.
60. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
61. Simmons LK, May PC, Tamaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN, Li WY (1994) Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373-379.
62. Sommer I, Schachner M (1981) Monoclonal antibodies (O1 to O4) to oligodendrocytes cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83:311-327.
63. Stephenson DT, Clemens JA (1992) In vivo effects of β-amyloid implants in rodents: lack of potentiation of damages associated with transient global ischemia. Brain Res 586:235-246.
64. Terry RD, Katzman R, Bick KL, editors (1994a) Alzheimer's disease. New York: Raven.
65. Terry RD, Masliah E, Hansen LA (1994b) Structural basis of the cognitive alterations in Alzheimer's disease. In: Alzheimer's disease (Terry RD, Katzman R, Bick KL, eds), pp 179-196. New York: Raven.
66. Thery C, Chamak B, Mallat M (1991) Free radical killing of neurons. Eur J Neurosci 3:1155-1164.
67. Verga L, Frangione B, Tagliavini F, Giaccone G, Migheli A, Bugiani O (1989) Alzheimer's disease and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett 105:294-299.
68. Whitson JS, Selkoe DJ, Cotman CW (1989) Amyloid β protein enhances the survival of hippocampal neurons in vitro. Science 243:1488-1490.
69. Wujek JR, Dority MD, Frederickson RCA, Brudent KR (1996) Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol Aging 17:107-113.
70. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya Y (1988) Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol (Berl) 77:113-119.
71. Yankner BA, Mesulam M-M (1991) Seminars in medicine of the Beth Israel Hospital, Boston: β-amyloid and the pathogenesis of Alzheimer's disease. N Engl J Med 325:1849-1857.
72. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-282.
73. Younkin SG (1995) Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann Neurol 37:287-288.